Congressman Off-Base in Ad Claiming Fauci Shipped Covid to Montana Before the Pandemic
Facts don’t support claims by a likely Republican Senate candidate that a federal research laboratory in Montana infected bats with a coronavirus from China before the covid-19 outbreak.
In a Fractious Rerun, GOP Rivals Haley and DeSantis Debate Health Care. Trump Sits It Out.
The fifth debate of the 2024 GOP presidential primary season took place days before Iowa Republicans will caucus to determine their pick for the top of the party’s ticket. The front-runner, former President Donald Trump, once again did not participate.
RFK Jr.’s Campaign of Conspiracy Theories Is PolitiFact’s 2023 Lie of the Year
Debate and speculation are heating up over whether Robert F. Kennedy Jr.’s presidential campaign will factor into the outcome of the 2024 election. But one thing is clear: Kennedy’s political following is built on a movement that seeks to legitimize conspiracy theories.
Candidates Clashed But Avoided Talk of Abortion at 4th GOP Primary Debate
Obamacare had its moment, but not until the faceoff’s final minutes. Front-runner Donald Trump again was not on the debate stage, leaving the other Republican presidential hopefuls to slug it out to break through and gain voters’ attention.
Explosive DeSantis-Newsom Debate Reflects Nation’s Culture Wars
The two governors exchanged heated verbal barbs when they faced off in a wide-ranging debate that covered various health-related topics, from abortion to gun violence.
Do Republican Spending Cuts Threaten Federal HIV Funding? For Some Programs, Yes.
Spending cuts proposed by a Republican-led House subcommittee would cut millions from HIV-related spending.
Another GOP Primary Debate … Another Night of Verbal Clashes
In a faceoff that took some strange turns, five presidential hopefuls focused on foreign affairs and inflation but still revealed the party’s political struggles over its abortion position. Once again, former President Donald Trump did not appear on the debate stage.
Trump Misplaced Blame When He Said Drug Shortages Were Biden’s Fault
Former President Donald Trump, who’s running for another term in the White House, recently blamed drug shortages on his successor, President Joe Biden. Our findings don’t align with Trump’s claims; by some measures, drug shortages increased more on Trump’s watch than on Biden’s.
GOP Presidential Primary Debate No. 2: An Angry Rematch and the Same Notable No-Show
Though never framed as a marquee issue, the topic of health care crept into the chaotic seven-way faceoff throughout the evening, highlighting Republican culture-war themes.
La publicación fue escrita por el activista anti-vacunas Steve Kirsch, quien ha hecho otras afirmaciones sobre las vacunas que han sido desacreditadas por PolitiFact y otros verificadores de datos.
Activist Misuses Federal Data to Make False Claim That Covid Vaccines Killed 676,000
Anti-vaccine tech entrepreneur Steve Kirsch, whose wild assertions have been repeatedly debunked, wrongly attributes deaths following vaccination to the vaccines themselves. The Centers for Disease Control and Prevention, which runs the database, calls that inaccurate and irresponsible.
Republican Debate Highlights Candidates’ Views on Abortion
Though health policies in general got little airtime, the discussion of whether candidates support a federal abortion ban underscored how Republicans, in a post-Roe environment, face political challenges on the issue.
Sen. Sanders Says Millions of People Can’t Find a Doctor. He’s Mostly Right.
The Vermont senator sees beefing up the primary care workforce as a critical step in expanding Americans’ access to health care.
A Windfall in Health Insurance Rebates? It’s Not as Crazy as It Sounds
The billion-dollar amount cited by former Sen. Al Franken, while an estimate, is likely very close to what insurers will owe this year under a provision of the Affordable Care Act that compels rebates when insurers spend too little on actual medical care.
Are US Prescription Drug Prices 10 Times Those of Other Nations? Only Sometimes
Sen. Bernie Sanders’ broad statement that some U.S. drug prices are 10 times those of other nations doesn’t paint the full picture. Studies we examined generally found that U.S. prices were two to four times those in other countries, not 10.
Republicans Vow Not to Cut Veterans’ Benefits. But the Legislation Suggests Otherwise.
Sparing veterans and defense spending, as Republicans promise, would be extremely difficult, requiring cuts of more than 20% in other parts of the budget. The Republicans’ Limit, Save, Grow Act already proposes a $2 billion cut to the Department of Veterans Affairs by taking back unspent covid relief funding.
Proposed Medicare Advantage Changes Cannot Accurately Be Called ‘Cuts,’ Experts Say
CMS advanced two proposed changes that could affect Medicare Advantage plans. One would allow the government to recover past overpayments. As a result, it could reduce those insurers’ profits, leading them to increase enrollees’ out-of-pocket costs or reduce benefits. But it’s inaccurate to characterize the changes as “cuts.”
Florida Gov. DeSantis Falsely Claims Bivalent Booster Boosts Chances of Covid Infection
Experts say the Florida governor’s conclusion could not be drawn from the study he cited, adding that the research focused on health care workers, who are likelier to be exposed to covid and more likely to be vaccinated. Those findings should not be applied to the general public.
Ad Goes Too Far With Claim That Joe Biden Promotes Surgery for Trans Teens
Even some medical experts who are skeptical of gender-affirming care say the White House is not promoting breast removal and genital surgery for teens. But that’s not what an ad, funded by a group led by a former adviser to President Donald Trump, would have you believe.
No, the Senate-Passed Reconciliation Bill Won’t Strip $300 Billion From Medicare
Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.
